LOS ANGELES, June 9, 2025 /PRNewswire/ -- TORL BioTherapeutics LLC (TORL), a clinical-stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend ...

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...

How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.

Federal regulators have authorized hundreds of drugs without evidence they work, and many are dangerous.

Healthcare Associates (HCA) is a primary care group practice at Beth Israel Deaconess Medical Center offering comprehensive health services to enhance quality of life for our patients. We provide ...

Over 500 million people worldwide suffer from diabetes-a disease that contributes to major complications such as stroke, ...

Including the replacement of the facial components, which used bone from Flores' hip, and left no external scarring, the ...

Governor Revives ‘Asset Test’ For Medi-Cal Applicants: Gov. Gavin Newsom has proposed tackling the rising costs of Medi-Cal ...

Researchers at ASCO provided a look at DB-1310 and iza-bren in genomically altered NSCLC, amid an overall survival miss for ...

A new targeted cancer drug, DB-1310, is showing early signs of effectiveness in patients with advanced solid tumors that have ...

A California cancer survivor was the recipient of the world's first in-human bladder transplant this month, thanks to a pair of Los Angeles doctors. Surgeons from Keck Medicine of USC and UCLA ...